Clinical Research Directory
Browse clinical research sites, groups, and studies.
I.V Papavrine for Labor Induction in Term PROM
Sponsor: Western Galilee Hospital-Nahariya
Summary
This prospective randomized controlled trial aims to evaluate whether intravenous administration of papaverine 12 hours after term PROM reduces the interval from membrane rupture to delivery and improves maternal and neonatal outcomes. Researchers will compare drug papaverine to a placebo
Official title: I.V Papavrine for Labor Induction in Term PROM: A Prospective Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
110
Start Date
2025-10-22
Completion Date
2027-10-22
Last Updated
2026-04-08
Healthy Volunteers
Yes
Conditions
Interventions
Papaverine arm
given 12 houres after rupture of membranes
Placebo
I.V seline
Locations (1)
Galilee Medical Center
Nahariya, Israel, Israel